How this supports a project
Material selection starts with the sequence and modification map, then aligns protected monomers, solid support, backbone chemistry, terminal handles, deprotection, and the analytical plan.
Material decisions across the workflow
Most synthetic oligonucleotides are assembled stepwise on a solid support. In a phosphoramidite cycle, detritylation, coupling, oxidation or sulfurization, and capping are repeated until the strand is complete. Modified monomers and functional handles must be compatible with the selected coupling and deprotection conditions.
The material list should therefore be built from the full strand design rather than from the sequence alone. Sugar and base modifications, backbone linkages, the 3′ terminus, and any terminal or internal conjugation site affect the required monomers, support, reagents, and purification strategy.
How material decisions enter the program
Define the construct
Record the sequence, strand format, sugar and base modifications, backbone pattern, termini, and intended conjugation sites.
Select monomers and solid support
Match protected phosphoramidites and the support or linker to the required 3′ end and planned cleavage conditions.
Set the assembly chemistry
Choose coupling, oxidation or sulfurization, capping, and detritylation conditions that are compatible with the modified building blocks.
Plan cleavage, deprotection, and purification
Check protecting-group compatibility and define how the full-length product will be separated from truncated or incompletely deprotected material.
Add and confirm the conjugate when required
A ligand or functional handle may be introduced during solid-phase assembly or by post-synthetic conjugation, followed by identity and purity confirmation.
What to define before an inquiry
Sequence and modification map
Mark every modified sugar, base, internucleotide linkage, and terminal group instead of supplying only the base sequence.
3′ architecture
Specify the required 3′ residue or functional group because it determines the solid support or support-bound linker.
Backbone pattern
State where phosphodiester or phosphorothioate linkages are required so oxidation and sulfurization steps can be planned.
Conjugation plan
Define the attachment position, ligand or label, spacer, reaction pair, and compatibility with assembly and deprotection.
Analytical expectations
Set the identity, purity, and conjugate-confirmation methods needed for the intended research stage.
Application boundary
This page organizes chemistry inputs and related catalog routes. It does not assess sequence selection, biological activity, delivery performance, clinical suitability, or regulatory status. Those questions require program-specific experimental evidence.
Related catalog and technical pages
Sources
- 1.Sustainability Challenges and Opportunities in Oligonucleotide Manufacturing (Journal of Organic Chemistry, 2021)
- 2.Solid-phase supports for oligonucleotide synthesis (Current Protocols in Nucleic Acid Chemistry, 2013)
- 3.The chemical evolution of oligonucleotide therapies of clinical utility (Nucleic Acids Research, 2017)
- 4.Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications (Molecules, 2019)